| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,648,000 | 3,450,000 | 4,778,000 | 4,218,000 | | Cost of Revenue | 2,195,000 | 2,168,000 | 3,637,000 | 3,029,000 | | | Gross Profit | 1,453,000 | 1,282,000 | 1,141,000 | 1,189,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 107,000 | 109,000 | 157,000 | 124,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 274,000 | 271,000 | 279,000 | 264,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,072,000 | 902,000 | 705,000 | 801,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 123,000 | 70,000 | (66,000) | (85,000) | | Earnings Before Interest And Taxes | 1,195,000 | 972,000 | 639,000 | 728,000 | | Interest Expense | 217,000 | 217,000 | 224,000 | 202,000 | | Income Before Tax | 978,000 | 755,000 | 415,000 | 526,000 | | Income Tax Expense | 380,000 | 293,000 | 167,000 | 178,000 | | Minority Interest | (12,000) |
-
|
-
| 12,000 | | | | Net Income From Continuing Ops | 598,000 | 462,000 | 248,000 | 348,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 586,000 | 462,000 | 248,000 | 348,000 | | Preferred Stock And Other Adjustments | 8,000 | (8,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $594,000 | $454,000 | $248,000 | $348,000 |
|
1.48% Nasdaq 
Income Statement
